This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Hospital Clinic De Barcelona, Fundación Cris De Investigación Para Vencer El Cáncer, Fundacion Para La Investigacion Biomedica Hospital 12 De Octubre. Active years: 2025-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
2 out of 27 
1 out of 1 
1 out of 1 
Years Active: 2025-2026
Title: Manel Juan Otero: Innovator in Biomedicine
Introduction
Manel Juan Otero is a prominent inventor based in Barcelona, Spain. He has made significant contributions to the field of biomedicine, particularly in the development of innovative therapies for cancer treatment. With a focus on bispecific antibodies and CAR T-cells, Otero's work is paving the way for new therapeutic approaches.
Latest Patents
Otero holds 2 patents that showcase his innovative research. His latest patents include "ANTI-CD19/ANTI-CD3 BISPECIFIC ANTIBODY, T CELLS SECRETING THE SAME" and "METHOD OF PREPARATION AND USE THEREOF - CAR T-CELLS AGAINST BCMA FOR THE TREATMENT OF MULTIPLE MYELOMA." These patents reflect his commitment to advancing cancer therapies and improving patient outcomes.
Career Highlights
Throughout his career, Otero has worked with esteemed institutions such as Hospital Clinic de Barcelona and Universität de Barcelona. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Otero has collaborated with notable colleagues, including Álvaro Urbano Ispizua and Lorena Pérez Amill. These partnerships have enhanced his research efforts and fostered a collaborative environment for innovation.
Conclusion
Manel Juan Otero is a distinguished inventor whose work in biomedicine is making a significant impact on cancer treatment. His innovative patents and collaborations highlight his dedication to advancing medical science and improving patient care.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile